Schedule 13D ownership disclosure

Altamira Therapeutics Ltd.

Security class unavailable · CUSIP: G0360L209

Event date: 2023-04-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-23-033296
Form type
SC 13D/A
Filer
Altamira Therapeutics Ltd.
CIK
CIK 1601936
Filed
Apr 27, 2023
Reporting period
Apr 17, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub